Background This report presents the design and initial validation of the Delft Car Pack (DCP), a mobile chest X-ray device developed for tuberculosis (TB) screening in rural areas of Africa, classified as a low and middle-income region (LMIC). TB screening in LMICs, particularly
...
Background This report presents the design and initial validation of the Delft Car Pack (DCP), a mobile chest X-ray device developed for tuberculosis (TB) screening in rural areas of Africa, classified as a low and middle-income region (LMIC). TB screening in LMICs, particularly in remote areas, poses significant challenges due to limited infrastructure, a shortage of trained radiologists, and a lack of reliable, portable screening equipment. To address these specific barriers, the DCP was developed, a pick-up-mounted X-ray system that combines mobility with Delft Imaging’s (DI) AI-powered detection software, CAD4TB. This integration enables dependable TB screening without requiring a radiologist. The DCP bridges the gap between Delft Imaging’s two primary transportable X-ray solutions: the Delft Light (DL) and the Mobile Clinic (MC). The DL is an ultra-portable, backpack-based X-ray unit, while the MC is a truck mounted system offering enhanced safety and image quality at a significantly higher cost. Although highly mobile, the DL presents challenges in safety, power consumption, image quality, and usability. Conversely, the MC addresses these limitations but is approximately ten times more expensive and cannot reach many hard-to-access locations. The DCP is designed to offer a balanced alternative, combining the affordability and mobility of the DL with the improved safety, usability, and image quality of the MC.
Method The design process was guided by the following core values: radiation safety, power consumption, X-ray image quality, usability, cost, and spatial fitting. These values were identified through field research that included qualitative interviews and Likert-scale surveys with experienced DL/MC users. Based on this user input, the values were translated into a set of design requirements, which were subsequently validated through conceptual analysis, radiation safety testing, and CAD modelling.
Results The key results are as follows. Radiation safety was assessed using a test setup, which showed that the radiographer receives a dose of 0.015 μSv per X-ray. This results in an annual exposure approximately three times lower than the 1 mSv safety threshold, assuming 200 X-rays are taken per day, five days per week. For power, the recommended daily battery capacity, including a 30% degradation margin, was determined to be approximately 956 Wh. To increase the X-ray quality in comparison to the DL, the DCP features a 110 kV X-ray tube (DL: 90 kV) connected to a digital detector by a rigid X-frame (source-to-image distance 1.25 m). The load-bearing capacity of this frame still requires testing. To enhance usability, the DCP includes a fixed lead barrier, supports simultaneous charging of the tube and detector during operation, and minimises user interaction to a single power cable. The estimated purchase price is expected to fall between that of the Delft Light and the Mobile Clinic. Finally, CAD models confirm that the DCP fits within a Toyota Hilux Double Cab and accommodates participant heights ranging from 1.45 to 1.90 m.
Conclusion This report outlines the initial design and validation phase of the Delft Car Pack (DCP). The system was assessed against the core values described earlier. Preliminary results show that radiation safety and power requirements have been successfully validated through empirical measurements. The validation of cost, spatial fitting, and usability appears promising, although usability still requires confirmation through field testing. Finally, the robustness requirements have yet to be verified through structural analysis and real-world evaluation. The prototype has already progressed to the development phase, reflecting Delft Imaging’s confidence in the DCP’s practical utility and potential impact. Continued development represents a crucial step toward increasing access to high-quality TB screening in remote and underserved settings.